Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | 10-K |
Revenues | 321.0 | 229.3 | 171.5 | 118.8 |
Revenue growth | 40.0% | 33.7% | 44.3% | |
Cost of goods sold | 207.0 | 151.7 | 139.5 | 91.6 |
Gross profit | 114.0 | 77.6 | 32.0 | 27.2 |
Gross margin | 35.5% | 33.8% | 18.7% | 22.9% |
Selling, general and administrative [+] | 45.2 | 27.3 | 18.7 | 15.3 |
General and administrative | 45.2 | 27.3 | 18.7 | 15.3 |
Research and development | 0.7 | | | |
Other operating expenses | 18.0 | 31.2 | 5.6 | -1.6 |
EBITDA [+] | 117.6 | 79.9 | 51.7 | 33.2 |
EBITDA growth | 47.2% | 54.5% | 56.0% | |
EBITDA margin | 36.6% | 34.9% | 30.2% | 27.9% |
Depreciation | 30.8 | 28.2 | 23.6 | 13.6 |
EBITA | 86.8 | 51.7 | 28.1 | 19.6 |
EBITA margin | 27.1% | 22.6% | 16.4% | 16.5% |
Amortization of intangibles | 36.7 | 32.6 | 20.4 | 6.1 |
EBIT [+] | 50.1 | 19.1 | 7.7 | 13.5 |
EBIT growth | 161.7% | 148.5% | -42.9% | |
EBIT margin | 15.6% | 8.3% | 4.5% | 11.4% |
Non-recurring items [+] | 15.6 | | | |
Asset impairment | 15.6 | | | |
Interest expense | 29.2 | 25.5 | 7.7 | 0.3 |
Interest expense | 29.2 | 25.5 | 7.7 | 0.3 |
Other income (expense), net [+] | | -0.4 | | -0.2 |
Other non-ooperating expenses | | 0.4 | | 0.2 |
Other | -29.2 | -25.9 | -7.7 | -0.4 |
Pre-tax income | 5.3 | -6.7 | 0.0 | 13.1 |
Income taxes | 0.5 | 0.3 | 0.0 | 0.0 |
Tax rate | 9.8% | | 76.7% | 0.0% |
Minority interest | 3.1 | 2.2 | | |
Net income | 1.7 | -9.2 | 0.0 | 13.1 |
Net margin | 0.5% | -4.0% | 0.0% | 11.0% |
|
Basic EPS [+] | $0.07 | ($0.44) | | |
Growth | -116.0% | | | |
Diluted EPS [+] | $0.07 | ($0.44) | | |
Growth | -116.0% | | | |
|
Dividends per share [+] | $1.02 | $10.21 | | |
Growth | -90.0% | | | |
|
Shares outstanding (basic) [+] | 24.1 | 20.9 | | |
Growth | 15.2% | | | |
Shares outstanding (diluted) [+] | 24.1 | 20.9 | | |
Growth | 15.6% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|